| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |